Insider Trades
News
globenewswire.comEdesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investorsglobenewswire.comJun 11
globenewswire.comEdesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injuryglobenewswire.comJun 5
globenewswire.comEdesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conferenceglobenewswire.comMay 19
globenewswire.comEdesa Biotech Reports Fiscal 2nd Quarter 2026 Resultsglobenewswire.comMay 14
globenewswire.comEdesa Biotech Invited for Oral Showcase at Respiratory Innovation Summitglobenewswire.comMar 31